Add-on Acquisition • Life Science

IMCD Acquires Cobapharma

On April 24, 2024, IMCD acquired life science company Cobapharma

Acquisition Context
  • This is IMCD’s 1st transaction in the Life Science sector.
  • This is IMCD’s 1st transaction in Spain.

Explore All 3110 Add-on Acquisition Life Science Deals - Search the Database Free


M&A Deal Summary

Date April 24, 2024
Target Cobapharma
Sector Life Science
Buyer(s) IMCD
Deal Type Add-on Acquisition

Target Company

Cobapharma

Barcelona, Spain
Cobapharma is a European distributor in the pharmaceutical and nutraceutical industry. The company provides an extensive portfolio of Active Pharmaceutical Ingredients (APIs) as well as nutraceutical ingredients. Cobapharma was formed in 2011 and is based in Barcelona, Spain.
Explore More Deals

Browse All 215,158 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

IMCD

Rotterdam, Netherlands

Category Company
Founded 1995
Sector Chemicals
Employees5,277
Revenue 4.7B EUR (2024)
DESCRIPTION

IMCD is a marketing, sales and distribution of specialty chemicals and food- and pharma ingredients, with offices and warehouses in 31 countries in Europe, Africa and Australia/Asia. IMCD was founded in 1995 and is based in Rotterdam, Netherlands.


Deal Context for Buyer #
Overall 56 of 64
Sector: Life Science 1 of 2
Type: Add-on Acquisition 50 of 57
Country: Spain 1 of 3
Year: 2024 4 of 7
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2024-03-20 Bretano

Santo Domingo, Costa Rica

Bretano is a specialty ingredients distributor in Latin America for the food industry and supplies chemicals to construction and other industrial markets. Established in 1961, Bretano is headquartered in Costa Rica, with commercial and logistics operations in Mexico, Guatemala and El Salvador

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-06-10 Selechimica

Milan, Italy

Selechimica is a pharmaceutical distributor operating a Active Pharmaceutical Ingredients (APIs) portfolio. Selechimica is based in Milan Italy.

Buy -